|
1
|
Zhang Y, Liu H, Li W, Yu J, Li J, Shen Z,
Ye G, Qi X and Li G: CircRNA_100269 is downregulated in gastric
cancer and suppresses tumor cell growth by targeting miR-630. Aging
(Albany NY). 9:1585–1594. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sitarz R, Skierucha M, Mielko J, Offerhaus
GJA, Maciejewski R and Polkowski WP: Gastric cancer: Epidemiology,
prevention, classification, and treatment. Cancer Manag Res.
10:239–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wagner AD, Syn NL, Moehler M, Grothe W,
Yong WP, Tai BC, Ho J and Unverzagt S: Chemotherapy for advanced
gastric cancer. Cochrane Database Syst Rev.
8:CD0040642017.PubMed/NCBI
|
|
5
|
Xu W, Yang Z and Lu N: Molecular targeted
therapy for the treatment of gastric cancer. J Exp Clin Cancer Res.
35:12016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li F, Ju Y, Guan Y and Zhao H: Tegafur
gimeracil oteracil potassium capsule induced acute interstitial
lung disease: A case report. Zhongguo Fei Ai Za Zhi. 17:53–56.
2014.(In Chinese). PubMed/NCBI
|
|
7
|
Kobayakawa M and Kojima Y:
Tegafur/gimeracil/oteracil (S-1) approved for the treatment of
advanced gastric cancer in adults when given in combination with
cisplatin: A review comparing it with other fluoropyrimidine-based
therapies. Onco Targets Ther. 4:193–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zimmermann C, Swami N, Krzyzanowska M,
Leighl N, Rydall A, Rodin G, Tannock I and Hannon B: Perceptions of
palliative care among patients with advanced cancer and their
caregivers. CMAJ. 188:E217–E227. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kelley AS and Morrison RS: Palliative care
for the seriously ill. N Engl J Med. 373:747–755. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
In H, Solsky I, Palis B, Langdon-Embry M,
Ajani J and Sano T: Validation of the 8th edition of the AJCC TNM
staging system for gastric cancer using the national cancer
database. Ann Surg Oncol. 24:3683–3691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eisenhauer A and Verweij J: 11 New
response evaluation criteria in solid tumors: RECIST GUIDELINE
VERSION 1.1. Eur J Cancer Suppl. 7:52009. View Article : Google Scholar
|
|
12
|
Chen ML, Liu J, Zhang J and Wu TJ:
Investigation for the incidences of cognitive emotion regulation,
quality of life, anxiety and depression in patients with chronic
heart failure. Chin Circ J. 32:956–959. 2017.
|
|
13
|
Liu N, Liu S, Yu N, Peng Y, Wen Y, Tang J
and Kong L: Correlations among psychological resilience,
self-efficacy, and negative emotion in acute myocardial infarction
patients after percutaneous coronary intervention. Front
Psychiatry. 9:12018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang JY, Verma V, Li M, Zhang W, Komaki
R, Lu C, Allen PK, Liao Z, Welsh J, Lin SH, et al: Proton beam
radiotherapy and concurrent chemotherapy for unresectable stage III
non-small cell lung cancer: Final results of a phase 2 study. JAMA
Oncol. 3:e1720322017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Plummer M, Franceschi S, Vignat J, Forman
D and de Martel C: Global burden of gastric cancer attributable to
helicobacter pylori. Int J Cancer. 136:487–490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng XJ, Lin JC and Tu SP: Etiology and
prevention of gastric cancer. Gastrointest Tumors. 3:25–36. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Y, Feng Y, Gao Y and Hou R: Clinical
benefits of combined chemotherapy with S-1, oxaliplatin, and
docetaxel in advanced gastric cancer patients with palliative
surgery. Onco Targets Ther. 9:1269–1273. 2016.PubMed/NCBI
|
|
19
|
Lv X, Zhang L, Huang R and Song W: A
clinical exploration of neoadjuvant chemotherapy with tegafur,
gimeracil, and oteracil potassium capsules combined with
oxaliplatin for advanced gastric cancer. Int J Clin Exp Med.
8:19030–19036. 2015.PubMed/NCBI
|
|
20
|
Yeo W, Lam KO, Law LY, Lee CC, Chiang CL,
Au KH, Mo FK, So TH, Lam KC, Ng WT and Li L: Adjuvant S-1
chemotherapy after curative resection of gastric cancer in Chinese
patients: Assessment of treatment tolerability and associated risk
factors. Hong Kong Med J. 23:54–62. 2017.PubMed/NCBI
|
|
21
|
Otsuka H, Fujii T, Toh U, Iwakuma N,
Takahashi R, Mishima M, Takenaka M, Kakuma T, Tanaka M and Shirouzu
K: Phase II clinical trial of metronomic chemotherapy with combined
irinotecan and tegafur-gimeracil-oteracil potassium in metastatic
and recurrent breast cancer. Breast Cancer. 22:335–342. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang T, Zhang SF, Qiu MQ and Li QL:
Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil
potassium) concurrent with 3-dimensional conformal radiotherapy for
newly diagnosed squamous cell carcinoma of the lung in elderly
patients. Cancer Radiother. 20:181–186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
May P, Normand C, Cassel JB, Del Fabbro E,
Fine RL, Menz R, Morrison CA, Penrod JD, Robinson C and Morrison
RS: Economics of palliative care for hospitalized adults with
serious illness: A meta-analysis. JAMA Intern Med. 178:820–829.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Polanski J, Jankowska-Polanska B,
Rosinczuk J, Chabowski M and Szymanska-Chabowska A: Quality of life
of patients with lung cancer. Onco Targets Ther. 9:1023–1028.
2016.PubMed/NCBI
|
|
25
|
Park SA, Chung SH and Lee Y: Factors
influencing the quality of life of patients with advanced cancer.
Appl Nurs Res. 33:108–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bicakli DH, Ozveren A, Uslu R, Dalak RM,
Cehreli R, Uyar M, Karabulut B and Akcicek F: The effect of
chemotherapy on nutritional status and weakness in geriatric
gastrointestinal system cancer patients. Nutrition. 47:39–42. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cotogni P, De Carli L, Passera R, Amerio
ML, Agnello E, Fadda M, Ossola M, Monge T, De Francesco A and
Bozzetti F: Longitudinal study of quality of life in advanced
cancer patients on home parenteral nutrition. Cancer Med.
6:1799–1806. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garcia-Anguita A, Kakourou A and Tsilidis
KK: Biomarkers of inflammation and immune function and risk of
colorectal cancer. Curr Colorectal Cancer Rep. 11:250–258. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li K, Zhang Q, Zhang Y, Yang J and Zheng
J: T-cell-associated cellular immunotherapy for lung cancer. J
Cancer Res Clin Oncol. 141:1249–1258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang F, Hou MX, Wu XL, Bao LD and Dong PD:
Impact of enteral nutrition on postoperative immune function and
nutritional status. Genet Mol Res. 14:6065–6072. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ding D, Feng Y, Song B, Gao S and Zhao J:
Effects of preoperative and postoperative enteral nutrition on
postoperative nutritional status and immune function of gastric
cancer patients. Turk J Gastroenterol. 26:181–185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun H, Song Y and Wang XY: Effects of
different anesthetic methods on cellular immune and neuroendocrine
functions in patients with hepatocellular carcinoma before and
after surgery. J Clin Lab Anal. 30:1175–1182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ivanova EA and Orekhov AN: T helper
lymphocyte subsets and plasticity in autoimmunity and cancer: An
overview. Biomed Res Int. 2015:3274702015. View Article : Google Scholar : PubMed/NCBI
|
